<p>Bioventus Inc. has appointed Ajay Dhankhar, PhD, to its Board of Directors as a Class II director, effective November 14, 2025. Dr. Dhankhar, currently the Chief Corporate Development &amp; Strategy Officer at Smith &amp; Nephew plc, will serve on the board until the company’s 2026 annual meeting of stockholders. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioventus Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001665988-25-000032), on November 17, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

<p>Bioventus Inc. has appointed Ajay Dhankhar, PhD, to its Board of Directors as a Class II director, effective November 14, 2025. Dr. Dhankhar will serve until the 2026 annual meeting of stockholders. He is currently the Chief Corporate Development & Strategy Officer at Smith & Nephew plc.</p>

Bioventus Appoints Ajay Dhankhar to Board of Directors